These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 34405769

  • 1. Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia.
    Wang J, Yang L, Dao FT, Wang YZ, Chang Y, Xu N, Chen WM, Jiang Q, Jiang H, Liu YR, Qin YZ.
    Leuk Lymphoma; 2022 Jan; 63(1):152-161. PubMed ID: 34405769
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of Tim-3 is associated with poor prognosis in acute myeloid leukemia.
    Wu Z, Ou J, Liu N, Wang Z, Chen J, Cai Z, Liu X, Yu X, Dai M, Zhou H.
    Cancer Med; 2023 Apr; 12(7):8956-8969. PubMed ID: 36545697
    [Abstract] [Full Text] [Related]

  • 3. [Characteristic and prognostic significance of leukemia stem cells associated antigens expressions in t (8;21) acute myeloid leukemia].
    Dao FT, Yang L, Wang YZ, Chang Y, Jiang Q, Jiang H, Liu YR, Huang XJ, Qin YZ.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Oct 14; 40(10):831-836. PubMed ID: 31775482
    [Abstract] [Full Text] [Related]

  • 4. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.
    Jajosky AN, Coad JE, Vos JA, Martin KH, Senft JR, Wenger SL, Gibson LF.
    Stem Cells Transl Med; 2014 Jul 14; 3(7):836-48. PubMed ID: 24855276
    [Abstract] [Full Text] [Related]

  • 5. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH, Sudha T, Godugu K, Elbaz O, Abdelghaffar HA, Hassan EE, Mousa SA.
    Oncotarget; 2016 Sep 06; 7(36):57811-57820. PubMed ID: 27506934
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Expression of Tim-3 on natural killer cells in patients with acute myeloid leukemia and its clinical significance].
    Ma JF, Li CX, Wu DP, Sun ZL, Yan CL.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Sep 14; 40(9):755-758. PubMed ID: 31648478
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C, Chen X, Yu X, Zhu Y, Ma C, Xia R, Ma J, Gu C, Ye L, Wu D.
    Int J Clin Exp Pathol; 2014 Sep 14; 7(10):6880-8. PubMed ID: 25400771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
    Witte KE, Ahlers J, Schäfer I, André M, Kerst G, Scheel-Walter HG, Schwarze CP, Pfeiffer M, Lang P, Handgretinger R, Ebinger M.
    Pediatr Hematol Oncol; 2011 Mar 14; 28(2):91-9. PubMed ID: 21214408
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.
    Kikushige Y, Shima T, Takayanagi S, Urata S, Miyamoto T, Iwasaki H, Takenaka K, Teshima T, Tanaka T, Inagaki Y, Akashi K.
    Cell Stem Cell; 2010 Dec 03; 7(6):708-17. PubMed ID: 21112565
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Kikushige Y, Miyamoto T, Yuda J, Jabbarzadeh-Tabrizi S, Shima T, Takayanagi S, Niiro H, Yurino A, Miyawaki K, Takenaka K, Iwasaki H, Akashi K.
    Cell Stem Cell; 2015 Sep 03; 17(3):341-52. PubMed ID: 26279267
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.